Evaluation and comparison of dissolution data derived from different modified release dosage forms: An alternative method

Journal of Controlled Release

Volumn 55, Issue 1, 1998, Pages 45-55

  Pillay, Viness ^a   Fassihi, Reza ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Controlled release system; Dissolution method modification; In vitro dissolution testing; Osmotic pump; Similarity factor application; Swellable sticking and floatable systems

Indexed keywords

DILTIAZEM; HYDROXYPROPYLMETHYLCELLULOSE; INORGANIC SALT; LACTOSE; NIFEDIPINE; THEOPHYLLINE;

ACCURACY; ARTICLE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; TECHNIQUE;

ALGORITHMS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; METHYLCELLULOSE; NIFEDIPINE; OSMOLAR CONCENTRATION; SOLUBILITY; THEOPHYLLINE;

EID: 0031723063     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00022-4     Document Type: Article

References (35)

1. Omelczuk M.O., McGinity J.W. The influence of thermal treatment on the physical-mechanical and dissolution properties of tablets containing poly (DL-lactic acid). Pharm. Res. 10(4):1993;542-548.
2. Wang Z., Horikawa T., Hirayama F., Uekama K. Design and in vitro evaluation of a modified release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose. J. Pharm. Pharmacol. 45(11):1993;942-946.
3. de Villiers M.M., Van der Watt J.G. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing. Pharm. Res. 11(11):1994;1557-1561.
4. Gordon M.S., Rudraraju V.S., Dani K., Chowan Z.T. Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. J. Pharm. Sci. 82(2):1993;220-226.
5. Rekhi G.S., Jambhekar S.S. Bioavailability and in vitro/in vivo correlation for propranolol hydrochloride extended release bead products prepared using aqueous polymeric dispersions. J. Pharm. Pharmacol. 48(12):1996;1276-1284.
6. Fassihi R.A., Munday D.L. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media. J. Pharm. Pharmacol. 41(6):1989;369-372.
7. Gouldson M.P., Deasy P.B. Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronization. J. Microencaps. 14(2):1997;137-153.
8. Naylor L.J., Bakatselou V., Dressman J.B. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm. Res. 10(6):1993;865-870.
9. Williams R.L., Upton R.A., Ball L., Braun R.L., Lin E.T., Liang-Gee W., Leeson L.J. Development of a new controlled release formulation of chlorpheniramine maleate using in vitro-in vivo correlations. J. Pharm. Sci. 80(1):1991;22-25.
10. Fassihi R.A., Ritschel W.A. Multiple-layer, direct-compression, controlled release system: In vitro and in vivo evaluation. J. Pharm. Sci. 82(7):1993;750-754.
11. Munday D.L., Fassihi R.A. In vitro-in vivo correlation studies on novel controlled release theophylline delivery system and on Theo-Dur tablets. Int. J. Pharm. 118:1995;251-255.
12. Grundy J.S., Anderson K.E., Rogers J.A., Foster R.T. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II Improved in vitro-in vivo correlation using a two-phase dissolution test. J. Contr. Rel. 48:1997;9-17.
13. Yu Z., Schwartz J.B., Sugita E.T. Theophylline controlled release formulations: in vitro-in vivo correlations. Biopharm. Drug Dispos. 17(3):1996;259-272.
14. Skoug J.W., Halstead G.W., Theis D.L., Freeman J.E., Fagan D.T., Rohrs B.R. Strategy for the development and validation of dissolution tests for solid oral dosage forms. Pharm. Tech. 20(5):1996;59-72.
15. Center for drug evaluation and research (CDER) at the Food and drug administration (FDA), SUPAC (1995).
16. Center for drug evaluation and research (CDER) at the Food and drug administration (FDA), IVIVC (1996).
17. Devane J., Butler J. The impact of in vitro-in vivo relationships on product development. Pharm Tech. 21(9):1997;146-159.
18. Cohen J.L., Hubert B.B., Leeson L.J., Rhodes C.T., Robinson J.R., Roseman T.J., Shefter E. The development of USP dissolution and drug release standards. Pharm. Res. 7(10):1990;983-987.
19. AAPS/USP wokshop on dissolution calibration and testing: Workshop report, Pharm. Res. 13(1) (1996) 6-9.
20. USP 23-NF18; United States Pharmacopoeial Convention, Inc.: Rockville, MD, 1995.
21. Soltero R.A., Hoover J.M., Jones T.F., Standish M. Effects of sinker shapes on dissolution profiles. J. Pharm. Sci. 78(1):1989;35-40.
22. Bocanegra L.M., Morris G.J., Jurewicz J.T., Mauger J.W. Fluid and particle laser doppler velocity measurements and mass transfer predictions for the USP paddle method dissolution apparatus. Drug Dev. Ind. Pharm. 16(9):1990;1441-1464.
23. Khoury N., Mauger J.W., Stephen H. Dissolution rate studies from a stationary disk/rotating fluid system. Pharm. Res. 5(8):1988;495-500.
24. Polli J.E., Rekhi G.S., Augsburger L.L., Shah V.P. Methods to compare dissolution profiles and rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm Sci. 86(6):1997;690-700.
25. Moore J.W., Flanner H.H. Mathematical comparison of dissolution profiles. Pharm. Tech. 20(6):1996;64-74.
26. Fassihi R. A novel device in conjunction with paddle method to replace the application of wire helix sinker to floating dosage form. Pharm. Res. 12(9):1995;s-298.
27. R. Fassihi, A. Razaghi, H. Kim, L. Yang, J. Fabian, Pitfalls in release studies of floatable or sticking delivery systems. Control. Rel. Soc. Proc. August 19-20 (1996) 121-122.
28. Kim H., Fassihi R. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I Diltiazem hydrochloride. Pharm. Res. 14(10):1997;1415-1421.
29. Rescigno A. Pharm Res. 9(7):1992;925-928.
30. Linder W.D., Lippold B.C. Drug release from hydrocolloid embeddings with high or low susceptibility to hydrodynamic stress. Pharm. Res. 12(11):1995;1781-1785.
31. J.S. Grundy, K.E. Anderson, J.A. Rogers, R.T. Foster, Nifedipine GITS in vivo-in vitro correlation. Control. Rel. Soc. Proc. August 19-20 (1996) 18-19.
32. Grundy J.S., Anderson K.E., Rogers J.A., Foster R.T. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test. J. Control. Release. 48:1997;1-8.
33. S.L. Ali, Nifedipine, in: K. Florey (Ed.), Analytical Profiles of Drug Substances, Vol. 18, Academic Press, New York, 1989, pp. 221-288.
34. U.S. department of health and human services, Food and drug administration, Center for drug evaluation and research, Guidance for industry: Dissolution testing of immediate release solid oral dosage forms, August 1997.
35. Kim H., Fassihi R.A. Application of a binary polymer system in drug release rate modulation. I. Characterization of release mechanism, J. Pharm. Sci. 86(3):1997;316-322.